Daniel S. Chen MD PhD

Summary

• Dr. Daniel Chen is Physician Scientist, Medical Oncologist and Immunologist based in San Carlos, CA, specializing in melanoma and the development of novel treatments for Cancer and other human diseases. He completed his medical education at the Keck School of Medicine at the University of Southern California, followed by a residency, fellowship and post-doctorate at Stanford University. He holds a BS in Biology from MIT. Dr. Chen is the Founder and CEO of Synthetic Design Lab and a founding partner at Genesis BioCapital, LLC, and previously served as an Attending Physician at Stanford Health Care. His other previous roles include Chief Medical Officer at IGM Biosciences and Vice President, Global Head of Cancer Immunotherapy at Genentech/Roche. Dr. Chen's expertise encompasses cancer immunotherapy, novel engineered therapeutics, oncology, virology, and immunology. He has been published in leading journals, including Nature and Immunity, and his work, including "Oncology meets Immunology: The Cancer-Immunity Cycle", has received numerous citations. Additionally, Dr. Chen has contributed to many clinical trials focused on immunotherapy and led the development of TECENTRIQ (anti-PD-L1) from first in human studies to multiple global approvals.